Discontinued — last reported Q4 '26
Business Segments · Exit and other-related costs
Prescription Technology Solutions — Exit and other-related costs
Year-over-year, this metric declined by 100.0%, from $3M to $0. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2019
Last reportedQ4 2026May 8, 2026
Rolls up toBusiness Exit Costs
How to read this metric
Higher costs indicate significant strategic shifts or business unit rationalization, whereas lower costs suggest operational continuity.
Detailed definition
Captures expenses associated with exiting specific business activities, facilities, or product lines within the Prescrip...
Peer comparison
Comparable to 'exit costs' or 'discontinued operations expenses' found in the segment reporting of large healthcare service providers.
Metric ID:
mck_segment_prescription_technology_solutions_exit_and_other_related_costsHistorical Data
23 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1M | $1M | $0 | $0 | $2M | $1M | $1M | $1M | $2M | $3M | $1M | $8M | $3M | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 |
| QoQ Change | — | +0.0% | -100.0% | — | — | -50.0% | +0.0% | +0.0% | +100.0% | +50.0% | -66.7% | +700.0% | -62.5% | -100.0% | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | +100.0% | +0.0% | — | — | +0.0% | +200.0% | +0.0% | +700.0% | +50.0% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | — | -100.0% |
Range$0 – $8M
CAGR-100.0%
Avg YoY Growth+45.8%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — exit and other-related costs?
- McKesson (MCK) reported prescription technology solutions — exit and other-related costs of $0 in Q4 2026.
- How has McKesson's prescription technology solutions — exit and other-related costs changed year-over-year?
- McKesson's prescription technology solutions — exit and other-related costs decreased by 100.0% year-over-year, from $3M to $0.
- What does prescription technology solutions — exit and other-related costs mean?
- Costs incurred from exiting specific business operations or facilities within the technology solutions segment.